Report

  1. Home
  2. MarketsandMarkets

Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027

Market Report I 2022-09-22 I 287 Pages I MarketsandMarkets

The veterinary pain management market is projected to reach USD 2.5 Billion by 2027 from USD 1.8 Billion in 2022, at a CAGR of 6.7% during the forecast period. This market is subsegmented into by Product, Application, Animal, End User, And Region.

Opioids segment holds second largest share in the veterinary pain management market by drug type in 2021
The veterinary pain management drugs market is segment into NSAIDs, opioids, local anesthetics, alpha-2 agonists, disease-modifying osteoarthritis drugs, and other drugs on the basis of drug type. In 2021, the opioids segment accounted for a second largest share of the veterinary pain management drugs market.
Laser therapy device segment holds largest share in the veterinary pain management market by device type in 2021
Based on types of veterinary pain management devices, the market is segmented into laser therapy and electromagnetic field therapy devices. The laser therapy devices segment accounted for the largest share in 2021. Laser therapy is effective in curing a wide range of acute and chronic pain conditions; it targets and cures the cause of pain, ruling out the need for painful invasive surgeries and further use of pain relief drugs. These advantages are expected to drive the growth of laser therapy devices in the veterinary pain management devices market.
Dog holds the largest share of Companion animal veterinary pain management market in 2021
Based on animal type, the veterinary pain management market is segmented into companion animals and livestock animals. The companion animals segment accounted for the largest share of the veterinary pain management market in 2021. The large share of this segment can be attributed to the increasing companion animal ownership, growing awareness about animal health among pet owners, and rising pet healthcare expenditure

China is projected to registered highest growth rate of the APAC veterinary pain management market in 2021
The China market is estimated to grow at the highest CAGR during the forecast period. The factors such as increasing number of veterinary surgeries, increasing pet insurance, increasing the demand of animal derived factors, and increasing veterinary hospitals and clinics are contributing the growth of China market in veterinary pain management market during forecast period.

A breakdown of the primary participants (supply-side) for the veterinary pain management market referred to for this report is provided below:
- By Company Type: Tier 1-45%, Tier 2-34%, and Tier 3-21%
- By Designation: C-level-26%, Director Level-30%, and Others-44%
- By Region: North America-35%, Europe-32%, Asia Pacific-25%, Latin America- 6%, and Middle East and Africa- 2%
The prominent players in the veterinary pain management market are Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (US), Elanco Animal Health Incorporated (US), Merck & Co., Inc. (US), Dechra Pharmaceuticals (UK), Vetoquinol (France), SeQuent Scientific Limited (India), Norbrook Laboratories Limited (Ireland), Ceva Sante Animale (France), Chanelle Pharma (Ireland), and K-Laser USA (US). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the veterinary pain management market.
Research Coverage:
The market study covers the veterinary pain management market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, application type, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the veterinary pain management market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.

1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION 40
1.2.1 INCLUSIONS & EXCLUSIONS 41
1.3 MARKET SCOPE 42
1.3.1 MARKETS COVERED 42
FIGURE 1 VETERINARY PAIN MANAGEMENT MARKET SEGMENTATION 42
1.3.2 REGIONAL MARKETS COVERED 43
1.3.3 YEARS CONSIDERED 43
1.4 CURRENCY CONSIDERED 44
TABLE 1 STANDARD CURRENCY CONVERSION RATES 44
1.5 LIMITATIONS 44
1.6 STAKEHOLDERS 44
1.7 SUMMARY OF CHANGES 45
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH APPROACH 46
2.2 RESEARCH METHODOLOGY DESIGN 46
FIGURE 2 VETERINARY PAIN MANAGEMENT MARKET: RESEARCH DESIGN 46
2.2.1 SECONDARY RESEARCH 47
2.2.1.1 Key data from secondary sources 48
2.2.2 PRIMARY DATA 49
FIGURE 3 PRIMARY SOURCES 49
2.2.2.1 Key data from primary sources 50
2.2.2.2 Insights from primary experts 51
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 51
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 52
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 52
2.3 MARKET SIZE ESTIMATION 53
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 54
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: VETERINARY PAIN MANAGEMENT MARKET (2021) 54
FIGURE 9 TOP-DOWN APPROACH 55
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 57
?
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 58
FIGURE 12 DATA TRIANGULATION METHODOLOGY 58
2.5 MARKET SHARE ESTIMATION 59
2.6 ASSUMPTIONS 59
2.7 RISK ASSESSMENT 59
3 EXECUTIVE SUMMARY 60
FIGURE 13 VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 60
FIGURE 14 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 61
FIGURE 15 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022 VS. 2027 (USD MILLION) 61
FIGURE 16 VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 62
FIGURE 17 VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 63
FIGURE 18 VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2022 VS. 2027 (USD MILLION) 63
FIGURE 19 VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 64
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF VETERINARY PAIN MANAGEMENT MARKET 65
4 PREMIUM INSIGHTS 66
4.1 VETERINARY PAIN MANAGEMENT MARKET OVERVIEW 66
FIGURE 21 GROWTH IN COMPANION ANIMAL ADOPTION AND INCREASING PREVALENCE OF ANIMAL DISEASES TO DRIVE MARKET GROWTH 66
4.2 VETERINARY PAIN MANAGEMENT MARKET: REGIONAL MIX 67
FIGURE 22 ASIA PACIFIC MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 67
4.3 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT AND COUNTRY (2021) 68
FIGURE 23 VETERINARY PAIN MANAGEMENT DRUGS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021 68
4.4 VETERINARY PAIN MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 69
FIGURE 24 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 69
4.5 VETERINARY PAIN MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS 70
FIGURE 25 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 70
5 MARKET OVERVIEW 71
5.1 INTRODUCTION 71
5.2 MARKET DYNAMICS 71
FIGURE 26 VETERINARY PAIN MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 71
5.2.1 MARKET DRIVERS 72
5.2.1.1 Growth in companion animal population 72
TABLE 2 PET POPULATION, BY ANIMAL, 2014-2020 (MILLION) 73
5.2.1.2 Increasing consumption of meat & milk 73
TABLE 3 PAST AND PROJECTED TRENDS IN CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING COUNTRIES 73
TABLE 4 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 74
5.2.1.3 Growing prevalence of diseases 74
5.2.1.4 Increasing number of veterinary practitioners in developed economies 75
TABLE 5 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012-2020 75
5.2.2 MARKET RESTRAINTS 75
5.2.2.1 Rising pet care costs 75
FIGURE 27 US: BASIC ANNUAL EXPENSES FOR DOGS AND CATS, 2021 76
5.2.3 MARKET OPPORTUNITIES 76
5.2.3.1 Increasing popularity of non-conventional and non-pharmaceutical treatment techniques 76
5.2.3.2 Untapped emerging markets 77
5.2.4 MARKET CHALLENGES 77
5.2.4.1 Stringent regulatory process 77
5.3 TECHNOLOGY ANALYSIS 77
5.3.1 KEY TECHNOLOGIES 77
5.3.1.1 Development of low-level light therapy/laser therapy/photobiomodulation 77
TABLE 6 SOME COMMERCIALLY AVAILABLE LASER THERAPY INSTRUMENTS 78
5.4 ECOSYSTEM ANALYSIS 78
TABLE 7 VETERINARY PAIN MANAGEMENT MARKET: ECOSYSTEM MAPPING 78
FIGURE 28 VETERINARY PAIN MANAGEMENT MARKET: ECOSYSTEM MARKET MAP 79
5.5 AVERAGE SELLING PRICE TRENDS 80
5.5.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY APPLICATION 80
TABLE 8 PRICING ANALYSIS OF PAIN MANAGEMENT PRODUCTS OFFERED BY LEADING PLAYERS (USD) 80
5.6 PATENT ANALYSIS 80
5.6.1 PATENT PUBLICATION TRENDS FOR VETERINARY PAIN MANAGEMENT PRODUCTS 80
FIGURE 29 PATENT PUBLICATION TRENDS (JANUARY 2012-AUGUST 2022) 81
5.6.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 81
FIGURE 30 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY PAIN MANAGEMENT (JANUARY 2012-JULY 2022) 82
FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY PAIN MANAGEMENT PATENTS (JANUARY 2012-JULY 2022) 83
5.7 VALUE CHAIN ANALYSIS 83
FIGURE 32 VETERINARY PAIN MANAGEMENT MARKET: VALUE CHAIN ANALYSIS 84
?
5.8 SUPPLY CHAIN ANALYSIS 84
FIGURE 33 VETERINARY PAIN MANAGEMENT MARKET: SUPPLY CHAIN ANALYSIS 85
5.9 PORTER'S FIVE FORCES ANALYSIS 86
FIGURE 34 VETERINARY PAIN MANAGEMENT MARKET: PORTER'S FIVE FORCES ANALYSIS 86
TABLE 9 VETERINARY PAIN MANAGEMENT MARKET: PORTER'S FIVE FORCES ANALYSIS 86
5.9.1 THREAT FROM NEW ENTRANTS 87
5.9.2 THREAT FROM SUBSTITUTES 87
5.9.3 BARGAINING POWER OF SUPPLIERS 88
5.9.4 BARGAINING POWER OF BUYERS 88
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 88
5.10 KEY CONFERENCES & EVENTS DURING 2022-2023 89
TABLE 10 VETERINARY PAIN MANAGEMENT MARKET: DETAILED LIST OF CONFERENCES & EVENTS 89
5.11 KEY STAKEHOLDERS & BUYING CRITERIA 90
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
FIGURE 35 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS 90
TABLE 11 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS 90
5.11.2 BUYING CRITERIA 91
FIGURE 36 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 91
TABLE 12 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 91
5.12 TRENDS AND DISRUPTIONS AFFECTING CUSTOMERS' BUSINESSES 92
FIGURE 37 VETERINARY PAIN MANAGEMENT MARKET: TRENDS AND DISRUPTIONS AFFECTING CUSTOMERS' BUSINESSES 92
5.13 TRADE ANALYSIS 92
5.14 INDUSTRY TRENDS 92
5.14.1 ADOPTION OF REGENERATIVE MEDICINE 92
5.15 REGULATORY ANALYSIS 93
5.15.1 REGULATORY LANDSCAPE 93
FIGURE 38 DEVELOPMENT AND APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS 95
5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.15.2.1 US 95
TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.15.2.2 Europe 97
TABLE 14 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
5.15.2.3 Rest of the world 98
TABLE 15 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
?
6 VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT 99
6.1 INTRODUCTION 100
TABLE 16 VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2020-2027 (USD MILLION) 100
6.2 DRUGS 100
6.2.1 DRUGS MARKET, BY TYPE 100
TABLE 17 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 101
TABLE 18 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 101
6.2.1.1 NSAIDs 102
6.2.1.1.1 Extensive use of NSAIDS to control pain and inflammation in animals to drive market 102
TABLE 19 VETERINARY PAIN MANAGEMENT DRUGS MARKET FOR NSAIDS, BY COUNTRY, 2020-2027 (USD MILLION) 102
6.2.1.2 Opioids 103
6.2.1.2.1 Advantages of opioids such as remarkable safety profile, high efficacy, and reversibility to promote adoption 103
TABLE 20 VETERINARY PAIN MANAGEMENT DRUGS MARKET FOR OPIOIDS, BY COUNTRY, 2020-2027 (USD MILLION) 103
6.2.1.3 Local anesthetics 104
6.2.1.3.1 Ability of local anesthetics to minimize post-operative pain in animals to support demand 104
TABLE 21 VETERINARY PAIN MANAGEMENT DRUGS MARKET FOR LOCAL ANESTHETICS, BY COUNTRY, 2020-2027 (USD MILLION) 104
6.2.1.4 Alpha-2 agonists 105
6.2.1.4.1 Excessive sedation caused and loss of muscle coordination may limit use of alpha-2 agonists 105
TABLE 22 VETERINARY PAIN MANAGEMENT DRUGS MARKET FOR ALPHA-2 AGONISTS, BY COUNTRY, 2020-2027 (USD MILLION) 105
6.2.1.5 Disease-modifying osteoarthritis drugs 106
6.2.1.5.1 Ability of DMOADs to stabilize joint membranes, help with joint cartilage repair, and improve joint lubrication to increase adoption 106
TABLE 23 VETERINARY PAIN MANAGEMENT DRUGS MARKET FOR DISEASE-MODIFYING OSTEOARTHRITIS DRUGS, BY COUNTRY, 2020-2027 (USD MILLION) 106
6.2.1.6 Other drugs 107
TABLE 24 OTHER VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 107
6.2.2 DRUGS MARKET, BY ROUTE OF ADMINISTRATION 108
TABLE 25 ROUTES OF ADMINISTRATION OF MAJOR VETERINARY PAIN MANAGEMENT DRUGS 108
TABLE 26 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 109
6.2.2.1 Oral 109
6.2.2.1.1 Affordability and ability to treat wide range of diseases to drive demand for oral drugs 109
TABLE 27 ORAL VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 110
6.2.2.2 Parenteral 110
6.2.2.2.1 Advantages such as injecting drugs at affected sites and no direct interaction with gastrointestinal tract make parenteral drugs popular 110
TABLE 28 PARENTERAL VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 111
6.2.2.3 Topical 111
6.2.2.3.1 Temporary effects of topical drugs compared with oral and parenteral drugs to hinder market growth 111
TABLE 29 TOPICAL VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 112
6.3 DEVICES 112
TABLE 30 VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 113
TABLE 31 VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 113
6.3.1 LASER THERAPY DEVICES 114
6.3.1.1 Effectiveness of laser therapy devices in curing wide range of acute and chronic pain conditions in animals to drive growth 114
TABLE 32 VETERINARY PAIN MANAGEMENT LASER THERAPY DEVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 114
6.3.2 ELECTROMAGNETIC THERAPY DEVICES 115
6.3.2.1 Adoption of electromagnetic therapy devices to grow in coming years due to their effectiveness and ease of handling 115
TABLE 33 VETERINARY PAIN MANAGEMENT ELECTROMAGNETIC THERAPY DEVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 115
7 VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION 116
7.1 INTRODUCTION 117
TABLE 34 VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 117
7.2 JOINT PAIN 117
TABLE 35 VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 118
TABLE 36 VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY COUNTRY, 2020-2027 (USD MILLION) 118
7.2.1 OSTEOARTHRITIS 119
7.2.1.1 Growing prevalence of osteoarthritis in companion animals to drive market growth 119
TABLE 37 VETERINARY PAIN MANAGEMENT MARKET FOR OSTEOARTHRITIS, BY COUNTRY, 2020-2027 (USD MILLION) 120
7.2.2 MUSCULOSKELETAL DISORDERS 120
7.2.2.1 Rising number of veterinary visits to drive adoption of pain management drugs for musculoskeletal disorders 120
TABLE 38 VETERINARY PAIN MANAGEMENT MARKET FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2020-2027 (USD MILLION) 121
7.3 POST-OPERATIVE PAIN 121
7.3.1 INCREASING NUMBER OF ANIMALS UNDERGOING SURGERY TO DRIVE GROWTH IN THIS MARKET SEGMENT 121
TABLE 39 VETERINARY PAIN MANAGEMENT MARKET FOR POST-OPERATIVE PAIN, BY COUNTRY, 2020-2027 (USD MILLION) 122
7.4 CANCER 122
7.4.1 NEED FOR PAIN MANAGEMENT AT ALL STAGES OF CANCER TREATMENT TO SUPPORT GROWTH 122
TABLE 40 VETERINARY PAIN MANAGEMENT MARKET FOR CANCER, BY COUNTRY, 2020-2027 (USD MILLION) 123
7.5 OTHER APPLICATIONS 124
TABLE 41 VETERINARY PAIN MANAGEMENT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2027 (USD MILLION) 124
8 VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE 125
8.1 INTRODUCTION 126
TABLE 42 VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 126
TABLE 43 VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 126
8.2 COMPANION ANIMALS 127
TABLE 44 VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 127
TABLE 45 VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2020-2027 (USD MILLION) 128
8.2.1 DOGS 128
8.2.1.1 Higher adoption rate of dogs than other companion animals to drive market growth 128
TABLE 46 DOG POPULATION, BY COUNTRY, 2012-2020 (MILLION) 129
TABLE 47 VETERINARY PAIN MANAGEMENT MARKET FOR DOGS, BY COUNTRY, 2020-2027 (USD MILLION) 130
8.2.2 CATS 130
8.2.2.1 Growing pet cat population to support growth 130
TABLE 48 CAT POPULATION, BY COUNTRY, 2012-2020 (MILLION) 131
TABLE 49 VETERINARY PAIN MANAGEMENT MARKET FOR CATS, BY COUNTRY, 2020-2027 (USD MILLION) 131
8.2.3 HORSES 132
8.2.3.1 Growing equine health awareness to drive growth 132
TABLE 50 EQUINE POPULATION, BY COUNTRY, 2012-2019 (THOUSAND) 132
TABLE 51 VETERINARY PAIN MANAGEMENT MARKET FOR HORSES, BY COUNTRY, 2020-2027 (USD MILLION) 133
8.2.4 OTHER COMPANION ANIMALS 133
TABLE 52 VETERINARY PAIN MANAGEMENT MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2020-2027 (USD MILLION) 134
8.3 LIVESTOCK ANIMALS 134
TABLE 53 VETERINARY PAIN MANAGEMENT FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 135
TABLE 54 VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2020-2027 (USD MILLION) 135
8.3.1 CATTLE 136
8.3.1.1 Growing consumption of meat to support market growth 136
TABLE 55 CATTLE POPULATION, BY COUNTRY, 2012-2019 (MILLION) 137
TABLE 56 VETERINARY PAIN MANAGEMENT MARKET FOR CATTLE, BY COUNTRY, 2020-2027 (USD MILLION) 137
8.3.2 SWINE 138
8.3.2.1 Growing incidence of infectious diseases to drive market growth 138
TABLE 57 SWINE POPULATION, BY COUNTRY, 2012-2019 (MILLION) 139
TABLE 58 VETERINARY PAIN MANAGEMENT MARKET FOR SWINE, BY COUNTRY, 2020-2027 (USD MILLION) 139
8.3.3 OTHER LIVESTOCK ANIMALS 140
TABLE 59 VETERINARY PAIN MANAGEMENT MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2020-2027 (USD MILLION) 140
9 VETERINARY PAIN MANAGEMENT MARKET, BY END USER 141
9.1 INTRODUCTION 142
TABLE 60 VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 142
9.2 VETERINARY HOSPITALS 142
9.2.1 GROWING INVESTMENTS IN EXPANDING VETERINARY HOSPITALS TO DRIVE MARKET GROWTH 142
TABLE 61 VETERINARY PAIN MANAGEMENT MARKET FOR HOSPITALS, BY COUNTRY, 2020-2027 (USD MILLION) 143
9.3 VETERINARY CLINICS 143
9.3.1 GROWING NUMBER OF PATIENT VISITS TO PROMOTE GROWTH IN THIS MARKET SEGMENT 143
TABLE 62 VETERINARY PAIN MANAGEMENT MARKET FOR CLINICS, BY COUNTRY, 2020-2027 (USD MILLION) 144
9.4 PHARMACIES & DRUG STORES 144
9.4.1 CONVENIENCE AND EASY ACCESS TO VETERINARY DRUGS TO MAKE PHARMACIES POPULAR ALTERNATIVES 144
TABLE 63 VETERINARY PAIN MANAGEMENT MARKET FOR PHARMACIES & DRUG STORES, BY COUNTRY, 2020-2027 (USD MILLION) 145
10 VETERINARY PAIN MANAGEMENT MARKET, BY REGION 146
10.1 INTRODUCTION 147
FIGURE 39 VETERINARY PAIN MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 147
TABLE 64 VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2020-2027 (USD MILLION) 148
10.2 NORTH AMERICA 148
FIGURE 40 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET SNAPSHOT 149
TABLE 65 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 149
TABLE 66 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 150
TABLE 67 NORTH AMERICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 150
TABLE 68 NORTH AMERICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 150
TABLE 69 NORTH AMERICA: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 151
TABLE 70 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 151
TABLE 71 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 151
TABLE 72 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 152
TABLE 73 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 152
TABLE 74 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 152
TABLE 75 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 153
10.2.1 US 153
10.2.1.1 Growing pet ownership to drive market growth 153
FIGURE 41 US: POPULATION OF DOGS, 2012-2020 (MILLION) 153
TABLE 76 HEALTHCARE EXPENDITURE ON COMPANION ANIMALS, 2018 VS. 2020 154
FIGURE 42 NUMBER OF VETERINARIANS IN US, 2016-2020 154
TABLE 77 US: FOOD-PRODUCING ANIMAL POPULATION, 2001-2019 (MILLION) 154
TABLE 78 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014-2020 155
TABLE 79 US: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 155
TABLE 80 US: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 155
TABLE 81 US: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 156
TABLE 82 US: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 156
TABLE 83 US: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 156
TABLE 84 US: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 157
TABLE 85 US: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 157
TABLE 86 US: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 157
TABLE 87 US: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS,
BY TYPE, 2020-2027 (USD MILLION) 158
TABLE 88 US: VETERINARY PAIN MANAGEMENT MARKET, BY END USER,
2020-2027 (USD MILLION) 158
10.2.2 CANADA 158
10.2.2.1 Growing pool of skilled veterinarians to support market growth 158
FIGURE 43 CANADA: COMPANION ANIMAL POPULATION, 2016-2020 (MILLION) 159
TABLE 89 CANADA: LARGE ANIMAL POPULATION, 2001-2019 (MILLION) 159
TABLE 90 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2020-2027 (USD MILLION) 160
TABLE 91 CANADA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE,
2020-2027 (USD MILLION) 160
TABLE 92 CANADA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 160
TABLE 93 CANADA: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 161
TABLE 94 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 161
TABLE 95 CANADA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 161
TABLE 96 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 162
TABLE 97 CANADA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 162
TABLE 98 CANADA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 162
TABLE 99 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 163
10.3 EUROPE 163
TABLE 100 EUROPE: COMPANION POPULATION, 2019 (MILLION) 164
TABLE 101 EUROPE: LIVESTOCK POPULATION, 2019 (MILLION) 164
TABLE 102 EUROPE: NUMBER OF VETERINARIANS, 2012-2019 165
TABLE 103 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 165
TABLE 104 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 166
TABLE 105 EUROPE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 166
TABLE 106 EUROPE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 166
TABLE 107 EUROPE: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 167
TABLE 108 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 167
TABLE 109 EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 167
TABLE 110 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 168
TABLE 111 EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 168
TABLE 112 EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 168
TABLE 113 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 169
10.3.1 GERMANY 169
10.3.1.1 Rising awareness about pet healthcare in Germany to promote market growth 169
TABLE 114 GERMANY: LIVESTOCK ANIMAL POPULATION, 2016-2019 (MILLION) 170
TABLE 115 GERMANY: COMPANION ANIMAL POPULATION, 2016-2019 (MILLION) 170
TABLE 116 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 170
TABLE 117 GERMANY: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 171
TABLE 118 GERMANY: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 171
TABLE 119 GERMANY: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 172
TABLE 120 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 172
TABLE 121 GERMANY: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 172
TABLE 122 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 173
TABLE 123 GERMANY: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 173
TABLE 124 GERMANY: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 173
TABLE 125 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 174
10.3.2 FRANCE 174
10.3.2.1 Favorable government policies promoting export of livestock products to support growth 174
TABLE 126 FRANCE: PET POPULATION, 2017-2020 (MILLION) 174
TABLE 127 FRANCE: LIVESTOCK ANIMAL POPULATION, 2016-2019 (MILLION) 175
TABLE 128 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 175
TABLE 129 FRANCE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 176
TABLE 130 FRANCE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 176
TABLE 131 FRANCE: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 177
TABLE 132 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 177
TABLE 133 FRANCE: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 177
TABLE 134 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 178
TABLE 135 FRANCE: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 178
TABLE 136 FRANCE: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 178
TABLE 137 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 179
10.3.3 UK 179
10.3.3.1 Increasing availability of animal health insurance to aid growth 179
TABLE 138 UK: PET POPULATION, 2017-2020 (MILLION) 180
TABLE 139 UK: LIVESTOCK ANIMAL POPULATION, 2016-2019 (MILLION) 180
TABLE 140 UK: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 180
TABLE 141 UK: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 181
TABLE 142 UK: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 181
TABLE 143 UK: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 182
TABLE 144 UK: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 182
TABLE 145 UK: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 182
TABLE 146 UK: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 183
TABLE 147 UK: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 183
TABLE 148 UK: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 183
TABLE 149 UK: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 184
10.3.4 ITALY 184
10.3.4.1 Growing demand for pork to propel market growth in Italy 184
TABLE 150 ITALY: PET POPULATION, 2017-2020 (MILLION) 184
TABLE 151 ITALY: LIVESTOCK ANIMAL POPULATION, 2016-2019 (MILLION) 185
TABLE 152 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 185
TABLE 153 ITALY: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 185
TABLE 154 ITALY: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 186
TABLE 155 ITALY: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 186
TABLE 156 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 186
TABLE 157 ITALY: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 187
TABLE 158 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 187
TABLE 159 ITALY: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 187
TABLE 160 ITALY: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 188
TABLE 161 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 188
10.3.5 SPAIN 188
10.3.5.1 Rising livestock population to make Spain a relatively large market 188
TABLE 162 SPAIN: PET POPULATION, 2017-2020 (MILLION) 189
TABLE 163 SPAIN: LIVESTOCK ANIMAL POPULATION, 2016-2019 (MILLION) 189
TABLE 164 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 190
TABLE 165 SPAIN: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 190
TABLE 166 SPAIN: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 190
TABLE 167 SPAIN: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 191
TABLE 168 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 191
TABLE 169 SPAIN: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 191
TABLE 170 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 192
TABLE 171 SPAIN: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 192
TABLE 172 SPAIN: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 192
TABLE 173 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 193
10.3.6 REST OF EUROPE (ROE) 193
TABLE 174 REST OF EUROPE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2019 (MILLION) 193
TABLE 175 REST OF EUROPE: LIVESTOCK POPULATION, BY COUNTRY, 2019 (MILLION) 194
TABLE 176 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 194
TABLE 177 REST OF EUROPE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 194
TABLE 178 REST OF EUROPE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 195
TABLE 179 REST OF EUROPE: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 195
TABLE 180 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 195
TABLE 181 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 196
TABLE 182 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 196
TABLE 183 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 196
TABLE 184 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 197
TABLE 185 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 197

10.4 ASIA PACIFIC 197
FIGURE 44 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET SNAPSHOT 198
TABLE 186 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 199
TABLE 187 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 199
TABLE 188 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 199
TABLE 189 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 200
TABLE 190 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 200
TABLE 191 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 200
TABLE 192 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 201
TABLE 193 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 201
TABLE 194 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 201
TABLE 195 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 202
TABLE 196 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 202
10.4.1 JAPAN 202
10.4.1.1 Growing pet insurance industry in Japan to support growth 202
TABLE 197 NUMBER OF DOMESTICATED DOGS AND CATS IN JAPAN, 2012-2020 (THOUSAND) 203
TABLE 198 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 203
TABLE 199 JAPAN: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 204
TABLE 200 JAPAN: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 204
TABLE 201 JAPAN: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 204
TABLE 202 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 205
TABLE 203 JAPAN: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 205
TABLE 204 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 205
TABLE 205 JAPAN: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 206
TABLE 206 JAPAN: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 206
TABLE 207 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 206
10.4.2 CHINA 207
10.4.2.1 Growing willingness to spend on pet health products to support growth 207
TABLE 208 CHINA: LIVESTOCK POPULATION, 2010-2019 (MILLION) 207
TABLE 209 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 208
TABLE 210 CHINA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 208
TABLE 211 CHINA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 208
TABLE 212 CHINA: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 209
TABLE 213 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 209
TABLE 214 CHINA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 209
TABLE 215 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 210
TABLE 216 CHINA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 210
TABLE 217 CHINA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 210
TABLE 218 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 211
10.4.3 INDIA 211
10.4.3.1 Economic growth and changing lifestyles to lead to significant growth in Indian animal health industry 211
TABLE 219 INDIA: LIVESTOCK POPULATION, 2007 VS. 2012 VS. 2019 (MILLION) 212
TABLE 220 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 212
TABLE 221 INDIA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 213
TABLE 222 INDIA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 213
TABLE 223 INDIA: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 213
TABLE 224 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 214
TABLE 225 INDIA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 214
TABLE 226 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 214
TABLE 227 INDIA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 215
TABLE 228 INDIA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 215
TABLE 229 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 215
10.4.4 REST OF ASIA PACIFIC 216
TABLE 230 REST OF ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 216
TABLE 231 REST OF ASIA PACIFIC: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 217
TABLE 232 REST OF ASIA PACIFIC: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 217
TABLE 233 REST OF ASIA PACIFIC: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 217
TABLE 234 REST OF ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 218
TABLE 235 REST OF ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 218
TABLE 236 REST OF ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 218
TABLE 237 REST OF ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 219
TABLE 238 REST OF ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 219
TABLE 239 REST OF ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 219
10.5 LATIN AMERICA 220
10.5.1 GROWING NUMBER OF PARAVETERINARY PROFESSIONALS IN LATIN AMERICA TO DRIVE GROWTH 220
TABLE 240 LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY, 2010-2019 (MILLION) 220
TABLE 241 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 221
TABLE 242 LATIN AMERICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 221
TABLE 243 LATIN AMERICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 221
TABLE 244 LATIN AMERICA: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 222
TABLE 245 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 222
TABLE 246 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 222
TABLE 247 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 223
TABLE 248 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 223
TABLE 249 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 223
TABLE 250 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 224
10.6 MIDDLE EAST & AFRICA 224
10.6.1 AVAILABILITY OF FUNDING TO PROMOTE ANIMAL HEALTHCARE TO SUPPORT MARKET GROWTH 224
TABLE 251 MIDDLE EAST: LIVESTOCK POPULATION, 2010 VS. 2019 (MILLION) 225
TABLE 252 AFRICA: FOOD-PRODUCING ANIMAL POPULATION, 2012 VS. 2014 VS. 2019 (MILLION) 225
TABLE 253 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 225
TABLE 254 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020-2027 (USD MILLION) 226
TABLE 255 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION) 226
TABLE 256 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 226
TABLE 257 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 227
TABLE 258 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020-2027 (USD MILLION) 227
TABLE 259 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020-2027 (USD MILLION) 227
TABLE 260 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 228
TABLE 261 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020-2027 (USD MILLION) 228
TABLE 262 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020-2027 (USD MILLION) 228
11 COMPETITIVE LANDSCAPE 229
11.1 MARKET OVERVIEW 229
11.2 KEY PLAYER STRATEGIES 229
FIGURE 45 VETERINARY PAIN MANAGEMENT MARKET: KEY PLAYER STRATEGIES 229
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 230
FIGURE 46 REVENUE ANALYSIS OF TOP PLAYERS IN VETERINARY PAIN MANAGEMENT MARKET 230
11.4 MARKET SHARE ANALYSIS (2021) 230
FIGURE 47 VETERINARY PAIN MANAGEMENT MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021 231
TABLE 263 VETERINARY PAIN MANAGEMENT MARKET: DEGREE OF COMPETITION 231
11.5 COMPANY EVALUATION QUADRANT (2021) 232
11.5.1 STARS 233
11.5.2 EMERGING LEADERS 233
11.5.3 PERVASIVE PLAYERS 233
11.5.4 PARTICIPANTS 233
FIGURE 48 VETERINARY PAIN MANAGEMENT MARKET: COMPANY EVALUATION QUADRANT (2021) 234
11.6 START-UP/SME EVALUATION QUADRANT (2021) 235
11.6.1 PROGRESSIVE COMPANIES 235
11.6.2 DYNAMIC COMPANIES 235
11.6.3 STARTING BLOCKS 235
11.6.4 RESPONSIVE COMPANIES 235
FIGURE 49 VETERINARY PAIN MANAGEMENT MARKET: START-UP/SME EVALUATION QUADRANT (2021) 236
11.7 COMPETITIVE BENCHMARKING 237
TABLE 264 VETERINARY PAIN MANAGEMENT MARKET: DETAILED LIST OF KEY START-UPS/SMES 237
TABLE 265 VETERINARY PAIN MANAGEMENT MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES) 237
11.8 COMPANY FOOTPRINT 238
TABLE 266 VETERINARY PAIN MANAGEMENT MARKET: OVERALL COMPANY FOOTPRINT 238
TABLE 267 VETERINARY PAIN MANAGEMENT MARKET: COMPANY PRODUCT FOOTPRINT 239
TABLE 268 VETERINARY PAIN MANAGEMENT MARKET: COMPANY APPLICATION FOOTPRINT 240
TABLE 269 VETERINARY PAIN MANAGEMENT MARKET: COMPANY ANIMAL TYPE FOOTPRINT 241
TABLE 270 VETERINARY PAIN MANAGEMENT MARKET: COMPANY END-USER FOOTPRINT 242
TABLE 271 VETERINARY PAIN MANAGEMENT MARKET: COMPANY REGIONAL FOOTPRINT 243
11.9 COMPETITIVE SCENARIO 244
TABLE 272 KEY DEALS, JANUARY 2019-AUGUST 2022 244
TABLE 273 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019-AUGUST 2022 244
TABLE 274 OTHER DEVELOPMENTS, JANUARY 2019-AUGUST 2022 244
12 COMPANY PROFILES 245
12.1 KEY PLAYERS 245
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 245
TABLE 275 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: BUSINESS OVERVIEW 245
FIGURE 50 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2021) 246
12.1.2 ZOETIS INC. 249
TABLE 276 ZOETIS INC.: BUSINESS OVERVIEW 249
FIGURE 51 ZOETIS INC.: COMPANY SNAPSHOT (2021) 250
12.1.3 ELANCO ANIMAL HEALTH INCORPORATED 253
TABLE 277 ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS OVERVIEW 253
FIGURE 52 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2021) 254
12.1.4 MERCK & CO., INC. 257
TABLE 278 MERCK & CO., INC.: BUSINESS OVERVIEW 257
FIGURE 53 MERCK & CO., INC.: COMPANY SNAPSHOT (2021) 258
12.1.5 DECHRA PHARMACEUTICALS 260
TABLE 279 DECHRA PHARMACEUTICALS: BUSINESS OVERVIEW 260
FIGURE 54 DECHRA PHARMACEUTICALS: COMPANY SNAPSHOT (2021) 261
12.1.6 VETOQUINOL 263
TABLE 280 VETOQUINOL: BUSINESS OVERVIEW 263
FIGURE 55 VETOQUINOL: COMPANY SNAPSHOT (2021) 264
12.1.7 SEQUENT SCIENTIFIC LIMITED 266
TABLE 281 SEQUENT SCIENTIFIC LIMITED: BUSINESS OVERVIEW 266
FIGURE 56 SEQUENT SCIENTIFIC LIMITED: COMPANY SNAPSHOT (2021) 266
12.1.8 NORBROOK LABORATORIES LIMITED 268
TABLE 282 NORBROOK LABORATORIES LIMITED: BUSINESS OVERVIEW 268
12.1.9 CEVA SANTE ANIMALE 270
TABLE 283 CEVA SANTE ANIMALE: BUSINESS OVERVIEW 270
12.1.10 CHANELLE PHARMA 272
TABLE 284 CHANELLE PHARMA: BUSINESS OVERVIEW 272
12.2 OTHER PLAYERS 274
12.2.1 K-LASER USA 274
TABLE 285 K-LASER USA: BUSINESS OVERVIEW 274
12.2.2 ASSISI ANIMAL HEALTH 275
TABLE 286 ASSISI ANIMAL HEALTH: BUSINESS OVERVIEW 275
12.2.3 MULTI RADIANCE MEDICAL 276
TABLE 287 MULTI RADIANCE MEDICAL: BUSINESS OVERVIEW 276
12.2.4 AVAZZIA 277
TABLE 288 AVAZZIA: BUSINESS OVERVIEW 277
12.2.5 SOUND TECHNOLOGIES 278
TABLE 289 SOUND TECHNOLOGIES: BUSINESS OVERVIEW 278
12.2.6 IRM ENTERPRISES PVT. LTD. 279
TABLE 290 IRM ENTERPRISES PVT. LTD.: BUSINESS OVERVIEW 279
12.2.7 ASHISH LIFE SCIENCE PVT. LTD. 280
TABLE 291 ASHISH LIFE SCIENCE PVT. LTD.: BUSINESS OVERVIEW 280
12.2.8 CENTURY PHARMACEUTICALS LTD. 281
TABLE 292 CENTURY PHARMACEUTICALS LTD.: BUSINESS OVERVIEW 281
12.2.9 VETINDIA PHARMACEUTICALS LTD. 282
TABLE 293 VETINDIA PHARMACEUTICALS LTD.: BUSINESS OVERVIEW 282
12.2.10 OUROFINO ANIMAL HEALTH 283
TABLE 294 OUROFINO ANIMAL HEALTH: BUSINESS OVERVIEW 283
12.2.11 LABINDIA HEALTHCARE PRIVATE LIMITED 285
TABLE 295 LABINDIA HEALTHCARE PRIVATE LIMITED: BUSINESS OVERVIEW 285
12.2.12 MORVEL LABORATORIES PVT. LTD. 286
TABLE 296 MORVEL LABORATORIES PVT. LTD.: BUSINESS OVERVIEW 286
12.2.13 RICHTER PHARMA AG 287
TABLE 297 RICHTER PHARMA AG: BUSINESS OVERVIEW 287
12.2.14 ZUCHE PHARMACEUTICALS PVT. LTD. 288
TABLE 298 ZUCHE PHARMACEUTICALS PVT. LTD.: BUSINESS OVERVIEW 288
12.2.15 FIDELIS ANIMAL HEALTH 289
TABLE 299 FIDELIS ANIMAL HEALTH: BUSINESS OVERVIEW 289
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 290
13.1 DISCUSSION GUIDE 290
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 295
13.3 AVAILABLE CUSTOMIZATIONS 297
13.4 RELATED REPORTS 297
13.5 AUTHOR DETAILS 298

  • Not Sure / Need Reassuring
    • Confirm Content

      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages

      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives

      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices

      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts

      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies

      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses

      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License

      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats

      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery

      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges

      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card

      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer

      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security

      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security

      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $4950.00
  • $6650.00
  • $8150.00
  • $10000.00
  • ADD TO BASKET
  • BUY NOW

Related Reports

Microcars Market by Category (Kei Cars, A00, Neighborhood Electric Vehicles, Quadricycles), Power Output (<5, 5-25, 26-40, >40 kW), End-use Application, Kei Cars and Quadricycles (Propulsion and Classification), and Region - Global Forecast to 2032
 Market Report I 2025-05-05 I 228 Pages
Coring Market by Technology (Rotary, Wireline, Sidewall Coring), Well Type (Exploration, Appraisal, Development), Application (Onshore, Offshore), End-use Industry (Oil & Gas, Geothermal, Carbon Capture & Storage), Region - Global Forecast to 2029
 Market Report I 2025-05-05 I 159 Pages
Dynamic Positioning System Market by Equipment Class (Class 1, Class 2, Class 3), System (Position Reference & Tracking, Thruster & Propulsion, Power Management, DP Control, Motion & Environment Sensor), Fit, Ship Type & Region - Global Forecast to 2030
 Market Report I 2025-05-05 I 289 Pages

Don't forget we can help save time with your search, contact us and we'll prepare and send options

Fire-resistant Lubricants Market by Type (HFA, HFB, HFC, HFDU, and HFDR), End-use Industry (Metal Processing, Mining, Power Generation, Aerospace, Marine, Construction, and Other End-use Industries), and Region - Global Forecast to 2030
 Market Report I 2025-05-05 I 258 Pages
OTR Tires Market by Application (Construction & Mining Equipment, Agriculture Tractors, ATVs, Industrial Equipment), Agriculture Tractor by Power Output, Tire Type (Radial, Solid, Bias), Rim Size, Retreading (Application & Process), Aftermarket, Region - Global Forecast to 2032
 Market Report I 2025-05-02 I 462 Pages